Pharmacology

BOTOX Now For Migraine Headaches?

Allergan announced today that the National Institute for Health and Clinical Excellence (NICE) is recommending BOTOX(botulinum toxin type A) for the prophylaxis (prevention) of headache in adults with chronic migraine*, specifically in patients who have n ...

Article - Anna Ohlden - May 10 2012 - 8:19pm

Mylan Launches Generic Lipitor In Five European Countries

PITTSBURGH and LYON, France, May 11, 2012 /PRNewswire/-- Mylan Inc. today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland. Mylan has received marketing auth ...

Article - Anna Ohlden - Aug 8 2012 - 12:09pm

New Innovations In Breast Cancer Pharmaceutical Market

As the second leading cause of death due to cancer in women, the pipeline for breast cancer therapeutics remains strong.  Although there are approximately 27 drugs on the market indicated for the treatment of breast cancer, there is currently an unmet nee ...

Article - Anna Ohlden - May 16 2012 - 11:30pm

Positive Phase 2 Clinical Data With Tivantinib In Hepatocellular Carcinoma

ArQule, Inc. and Daiichi Sankyo, Co., Ltd. (TSE 4568) today announced that an oral presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) will feature Phase 2 trial data with tivantinib as a single agent investigational sec ...

Article - Anna Ohlden - May 18 2012 - 5:30pm

Anesthesia Drugs $7 Billion Market In U.S. By 2015

The 'Anesthesia Drugs Market (2011- 2015)- U.S. Market Entry Study' analyzes and studies the U.S. market for intravenous anesthesia drugs with special focus on ketamine, distribution structure of anesthesia drugs in U.S., potential buyers, expor ...

Article - Anna Ohlden - May 20 2012 - 5:09pm

Viagra- Now For Kids!

A double-blind, placebo-controlled, crossover trial of sildenafil, brand name Viagra, showed improvement in echocardiogram measures of myocardial performance in children and young adults after Fontan surgery- basically, kids with congenital heart defects w ...

Blog Post - Hank Campbell - May 17 2012 - 4:06pm

Zebinix Once-Daily Epilepsy Treatment Now Available In Sweden

Reimbursement granted for Zebinix (eslicarbazepine acetate) as adjunctive therapy for adults with partial-onset seizures   Eisai Europe Limited has announced the launch of Zebinix which will receive full reimbursement from Swedish health authorities.   On ...

Article - Anna Ohlden - May 27 2012 - 9:00am

Promising Phase II Data For Tiotropium In Adolescent Asthma Patients

A Phase II study presented today at the 2012 Annual Meeting of the American Thoracic Society showed positive results for once-daily tiotropium via the Respimat(R) Soft Mist(TM) Inhaler (SMI) device in adolescents with symptomatic, moderate, persistent ast ...

Article - Anna Ohlden - May 26 2012 - 9:00am

Data From Brentuximab Vedotin (SGN-35) Pivotal Phase II Trial

Results from a pivotal phase II trial of brentuximab vedotin, published in the Journal of Clinical Oncology, showed that 86% of patients with relapsed or refractory systemic anaplastic large cell lymphoma (sALCL),[1] achieved the primary endpoint of objec ...

Article - Anna Ohlden - May 23 2012 - 6:36pm

Positive Phase 2 Results For Lipid-Lowering PCSK9 Antibody

 Sanofi and Regeneron Pharmaceuticals, Inc. today announced additional positive results from a Phase 2 trial of SAR236553/REGN727 (Study 1003, NTC01266876) in patients with heterozygous familial hypercholesterolemia (heFH). SAR236553/REGN727 is a subcutan ...

Article - Anna Ohlden - May 26 2012 - 11:39pm